CXCL12 and acute myeloid leukemia: In addition, BM fluid from AML patients had increased levels of SDF-1 compared with that of serum (1844 ± 300.2 ng/mL vs. 1123 ± 168.9 ng/mL, P = 0.0494) (Fig. 3f).